Pembrolizumab 100 MG in 4 ML Injection

DRUG2 trials

Sponsors

Centre Leon Berard, Universitair Ziekenhuis Brussel

Conditions

Metastatic Breast CancerNon Small Cell Lung CancerSolid Tumor

Phase 2

Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide

CompletedNCT03139851

Centre Leon BerardMetastatic Breast Cancer

Start: 2017-06-27End: 2019-09-18Updated: 2021-09-10

Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors

Universitair Ziekenhuis BrusselNon Small Cell Lung Cancer, Solid Tumor

Start: 2020-09-22End: 2023-12-31Target: 36Updated: 2022-09-14

Related Papers

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)<sup>+</sup>/CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumors.

2024-07-022 citations

694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)<sup>+</sup>/CD141(BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumors

Regular and Young Investigator Award Abstracts2023-10-31